Pharmaron major shareholders reduce stake, triggering disclosure threshold

Pharmaron Beijing Co., Ltd. announced that its major shareholders, Shenzhen Zhongkang Chengc Investment Partnership and its concerted party, Shenzhen Zhonglong Chengc Investment Partnership, have reduced their shareholdings, triggering a 1% integer multiple threshold. From December 11, 2025, to December 19, 2025, Zhongkang Chengc and Zhonglong Chengc collectively decreased their holdings by 18,481,900 shares, representing 1.04% of the company's total share capital.

Specifically, Zhongkang Chengc reduced its holdings by 3.7m shares (0.21%) through block trades, while Zhonglong Chengc reduced its holdings by 14.78m shares (0.83%) through centralized bidding transactions. Prior to this reduction, Zhongkang Chengc held 222.68m shares (12.52%), and Zhonglong Chengc held 26.27m shares (1.48%).

Following these transactions, Zhongkang Chengc's stake now stands at 218.98m shares (12.31%), and Zhonglong Chengc's stake is 11.49m shares (0.65%). The combined total holding of both parties has decreased from 248.95m shares (14.00%) to 230.47m shares (12.96%). The reduction aligns with previously disclosed plans and is not expected to impact the company's governance or operations.